Fluid Loading Countermeasures
NCT06467812 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2024-07-10
Summary
The purpose of Fluid Loading Countermeasures is to determine how the volume of blood and of plasma (liquid part of blood) change during a normal day, how these are affected by drinking an additional amount of fluid either as water and salt tablets (as astronauts do) or an electrolyte beverage (similar to but tastes saltier than Gatorade®), and how altering the timing at which the additional fluid is consumed affects blood and plasma volume. This study observes how blood volume changes over \~9 hours of the day during 4 separate visits in healthy participants. During 1 visit participants will drink a small amount of water throughout the visit. During the other 3 study visits participants will drink the small amount of water plus either more water with salt tablets or an electrolyte solution. Consuming the additional fluids is called "fluid loading". This study is meant to simulate the food and fluid consumption of astronauts on landing day. The goal of this study is to determine the magnitude of plasma volume change that occurs with each condition of the protocol. (ICF 1.1, 3.1)
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Salt Tablets
Three doses of 4 Salt Tablets (1gm) will be taken with 400mL of water on day 2 (1200ml total) between \~8am and \~12pm during the testing day, which runs from \~7am to \~3:30pm.
- DIETARY_SUPPLEMENT
-
Electrolyte Solution
Three doses of 400mL of the Electrolyte Solution dissolved in water (1200 mL total) will be consumed on day 3 between \~8am and \~12pm during the testing day, which runs from \~7am to \~3:30pm. On day 4 the Electrolyte Solution Single Bolus will be consumed in a single dose of 1200mL at \~12pm during the testing day. The ingredients are included below for the two flavors offered. Orange flavor: Water, Dextrose with Maltodextrin, Aspartame, Acesulfame Potassium, Sodium Citrate, Salt, Citric Acid, Maltodextrin, Natural Flavor, Calcium Phosphate, Contains less than 2% Of Ascorbic Acid (Vitamin C), Artificial Flavor, Artificial Color, Red 40, Yellow 5, BHA (Butylated Hydroxyanisole). Lemonade flavor: Water, Dextrose with Maltodextrin, Aspartame, Acesulfame Potassium, Sodium Citrate, Salt, Citric Acid, Calcium Phosphate, Maltodextrin, Contains less than 2% Of Ascorbic Acid (Vitamin C), Natural Flavor, Artificial Color, Yellow 5, BHA.
Sponsors & Collaborators
-
National Aeronautics and Space Administration (NASA)
lead FED
Principal Investigators
-
Jason R. Lytle, PhD · National Aeronautics and Space Administration (NASA)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-01
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers
NCT05428748 ·Status: COMPLETED ·Phase: NA
-
Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)
NCT01128413 ·Status: TERMINATED ·Phase: NA
-
Crystalloid FLUID Choices for Resuscitation of Hospital Patients
NCT02721485 ·Status: COMPLETED ·Phase: NA
-
Human Hydration Status Monitoring
NCT01124903 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia
NCT01110655 ·Status: UNKNOWN ·Phase: NA
-
Minimal Volume for Fluid Challenge in Post-operative Patients
NCT02569008 ·Status: COMPLETED ·Phase: NA
-
Fluid and Salt Restriction in Decompensated Heart Failure Patients
NCT01133236 ·Status: COMPLETED ·Phase: NA
-
Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients
NCT06370975 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Parenteral Hydration in Advanced Cancer Patients
NCT00423722 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Response to the End-expiratory Occlusion Test to Titrate Fluid Challenge in Operating Room.
NCT06627907 ·Status: NOT_YET_RECRUITING
-
Balanced Solutions and Plasma Electrolytes
NCT03537898 ·Status: COMPLETED ·Phase: NA
-
Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury
NCT04522635 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Device for Rapid Fluid Administration
NCT03074682 ·Status: COMPLETED ·Phase: NA
-
Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain
NCT01168947 ·Status: COMPLETED ·Phase: NA
-
Plasma Sodium and Sodium Administration in the ICU
NCT06037928 ·Status: UNKNOWN
-
Using Hydration Monitor to Detect Changes in the Hydration Status Athletes
NCT02206581 ·Status: COMPLETED
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
NCT05428228 ·Status: RECRUITING ·Phase: NA
-
Starch or Saline After Cardiac Surgery
NCT00964015 ·Status: TERMINATED ·Phase: NA
-
Maintenance Intravenous Fluids in Children
NCT00621348 ·Status: COMPLETED ·Phase: PHASE3
-
Physiological Effects of Lactate in Individuals With Chronic Heart Failure
NCT06121323 ·Status: COMPLETED ·Phase: NA
-
Thirst-guided Subject-controlled Rehydration in Healthy Volunteers
NCT03932890 ·Status: UNKNOWN ·Phase: NA
-
Use of a Mini-fluid Bolus to Identify Fluid Responsiveness
NCT03058653 ·Status: WITHDRAWN ·Phase: NA
-
Exploring Water-free Sodium Storage
NCT06872645 ·Status: RECRUITING ·Phase: NA
-
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
NCT01227512 ·Status: TERMINATED ·Phase: PHASE3
-
Perioperative Fluid Management: Goal-directed Versus Restrictive Strategy
NCT02625701 ·Status: COMPLETED ·Phase: PHASE3